Rchr
J-GLOBAL ID:202401021033699860   Update date: Aug. 29, 2024

Nagato Toshihiro

Nagato Toshihiro
Research theme for competitive and other funds  (3):
  • 2021 - 2024 鼻性NK/T細胞リンパ腫を治癒に導く複合的免疫療法の確立
  • 2018 - 2021 Developing novel immunotherapy against nasal NK/T cell lymphoma
  • 2012 - 2015 A foundational study for targeted therapy against EB virus and tumor growth factor in nasal NK/T-cell lymphoma
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page